ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Elevance Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$430.23+1.97 (+0.46%)
Close on Oct 19, 2026
- Market cap
- $93.75B
- P/E (TTM)
- 19.1
- Dividend yield
- –
Elevance Health, Inc. revenue by segment
By business segment
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segments | $7.20B | $7.86B | $8.50B | $8.28B | – | – | – | – | – | – | -8.4% |
| Health Benefits | $4.16B | $6.24B | $6.89B | $6.02B | $5.85B | $5.13B | – | – | – | – | -33.4% |
| Total Carelon | $3.38B | $2.89B | $2.66B | $2.40B | – | – | – | – | – | – | +16.9% |
| CarelonRx | $2.42B | $2.17B | $1.98B | $1.87B | $1.68B | $1.36B | – | – | – | – | +11.3% |
| Carelon Services | $960.00M | $717.00M | $680.00M | $535.00M | $187.00M | $28.00M | – | – | – | – | +33.9% |
| Corporate & Other | -$337.00M | -$1.27B | -$1.04B | -$142.00M | – | – | – | – | – | – | -73.5% |
| Other [Member] | – | – | – | $354.00M | -$9.00M | -$126.00M | -$89.00M | -$102.00M | -$114.00M | -$174.00M | – |
| Commercial and Specialty Business Segment [Member] | – | – | – | $2.93B | $2.75B | $2.68B | $4.03B | $3.60B | $2.85B | $3.15B | – |
| Government Business [Member] | – | – | – | $3.30B | $3.06B | $2.44B | $2.06B | $1.93B | $1.44B | $1.83B | – |
| CarelonRx Segment [Member] | – | – | – | $1.87B | $1.68B | $1.36B | – | – | – | – | – |
| Total | – | – | $2.66B | $2.40B | $1.87B | $1.39B | – | – | – | – | – |
| Segment Eliminations [Member] | – | – | $0 | $0 | $0 | $0 | – | – | – | – | – |
| Corporate & Other Segment | – | – | -$1.04B | -$142.00M | -$162.00M | -$154.00M | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $24.47B | $22.63B | $19.45B | $14.98B | – | – | – | – | – | – | 12.3% | +8.1% |
| Service fees | $8.48B | $8.41B | $7.90B | $7.45B | – | – | – | – | – | – | 4.3% | +0.8% |
By region
From the segment and revenue-disaggregation notes of Elevance Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.